Apellis Pharmaceuticals, Inc. (APLS) Expected Move

Expected move estimates the probable price range for a given period based on at-the-money options pricing. It reflects the market consensus for volatility over the selected timeframe.

Apellis Pharmaceuticals, Inc. (APLS) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $5.25B, listed on NASDAQ, employing roughly 705 people, carrying a beta of -0.25 to the broader market. Apellis Pharmaceuticals, Inc. Led by Cedric Francois, public since 2017-11-09.

Expected move analysis estimates the probable price range implied by options pricing. No recent options activity for APLS as of 2026-07-17; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how expected move is reported and how to read the data →